|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$30.58 |
$30.66 |
$30.23 |
$30.27 |
1.59M | 03/25/2024 |
$30.27 |
$30.48 |
$30.08 |
$30.28 |
1.32M | 03/26/2024 |
$30.22 |
$30.39 |
$30.02 |
$30.23 |
1.54M | 03/27/2024 |
$30.42 |
$30.54 |
$30.18 |
$30.45 |
1.42M | 03/28/2024 |
$30.50 |
$30.80 |
$30.30 |
$30.37 |
2.89M |
|
Royalty Pharma is a buyer of biopharmaceutical royalties. The royalties in Co.'s marketed portfolio related to approved products include: cystic fibrosis franchise, which consists of Co.'s right to receive royalty payments on the sale of various products for use in the treatment of cystic fibrosis, including Kalydeco (ivacaftor), Orkambi (lumacaftor and ivacaftor), Symdeko/Symkevi (tezacaftor and ivacaftor) and Trikafta/Kaftrio (elexacaftor, tezacaftor and ivacaftor); and Tysabri, which is a monoclonal antibody for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. | |
|
Royalty Pharma (RPRX) has the following price history information. Looking back at RPRX historical stock prices for the last five trading days, on March 22, 2024, RPRX opened at $30.58, traded as high as $30.66 and as low as $30.23, and closed at $30.27. Trading volume was a total of 1.59M shares. On March 25, 2024, RPRX opened at $30.27, traded as high as $30.48 and as low as $30.08, and closed at $30.28. Trading volume was a total of 1.32M shares. On March 26, 2024, RPRX opened at $30.22, traded as high as $30.39 and as low as $30.02, and closed at $30.23. Trading volume was a total of 1.54M shares. On March 27, 2024, RPRX opened at $30.42, traded as high as $30.54 and as low as $30.18, and closed at $30.45. Trading volume was a total of 1.42M shares. On March 28, 2024, RPRX opened at $30.50, traded as high as $30.80 and as low as $30.30, and closed at $30.37. Trading volume was a total of 2.89M shares.
RPRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Royalty Pharma shares, starting with a $10,000 purchase of RPRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
06/16/2020 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$44.50 |
|
End price/share: |
$30.37 |
|
Starting shares: |
224.72 |
|
Ending shares: |
242.10 |
|
Dividends reinvested/share: |
$2.75 |
|
Total return: |
-26.48% |
|
Average Annual Total Return: |
-7.81% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,351.55 |
|
Years: |
3.78 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/16/2020 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$44.50 |
|
End price/share: |
$30.37 |
|
Dividends collected/share: |
$2.75 |
|
Total return: |
-25.57% |
|
Average Annual Total Return: |
-7.51% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,442.48 |
|
Years: |
3.78 |
|
|
|
Date |
Close |
03/22/2024 | $30.27 | 03/25/2024 | $30.28 | 03/26/2024 | $30.23 | 03/27/2024 | $30.45 | 03/28/2024 | $30.37 |
|
|